NVST
Price
$19.51
Change
-$0.24 (-1.22%)
Updated
Jul 18 closing price
Capitalization
3.67B
12 days until earnings call
TMDX
Price
$109.79
Change
-$2.73 (-2.43%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
2.4B
11 days until earnings call
Interact to see
Advertisement

NVST vs TMDX

Header iconNVST vs TMDX Comparison
Open Charts NVST vs TMDXBanner chart's image
Envista Holdings
Price$19.51
Change-$0.24 (-1.22%)
Volume$1.98M
Capitalization3.67B
TransMedics Group
Price$109.79
Change-$2.73 (-2.43%)
Volume$8.24K
Capitalization2.4B
NVST vs TMDX Comparison Chart in %
Loading...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVST vs. TMDX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Hold and TMDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 19, 2025
Stock price -- (NVST: $19.75 vs. TMDX: $112.52)
Brand notoriety: NVST and TMDX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NVST: 57% vs. TMDX: 66%
Market capitalization -- NVST: $3.67B vs. TMDX: $2.4B
NVST [@Medical Specialties] is valued at $3.67B. TMDX’s [@Medical Specialties] market capitalization is $2.4B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green whileTMDX’s FA Score has 0 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • TMDX’s FA Score: 0 green, 5 red.
According to our system of comparison, TMDX is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 3 TA indicator(s) are bullish while TMDX’s TA Score has 4 bullish TA indicator(s).

  • NVST’s TA Score: 3 bullish, 5 bearish.
  • TMDX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TMDX is a better buy in the short-term than NVST.

Price Growth

NVST (@Medical Specialties) experienced а -4.68% price change this week, while TMDX (@Medical Specialties) price change was -9.83% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.65%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -2.13%.

Reported Earning Dates

NVST is expected to report earnings on Oct 29, 2025.

TMDX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Medical Specialties (-0.65% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVST($3.67B) has a higher market cap than TMDX($2.4B). TMDX YTD gains are higher at: 80.465 vs. NVST (2.385). NVST has higher annual earnings (EBITDA): 171M vs. TMDX (-7.7M). NVST has more cash in the bank: 940M vs. TMDX (395M). TMDX has less debt than NVST: TMDX (516M) vs NVST (1.65B). NVST has higher revenues than TMDX: NVST (2.57B) vs TMDX (242M).
NVSTTMDXNVST / TMDX
Capitalization3.67B2.4B153%
EBITDA171M-7.7M-2,220%
Gain YTD2.38580.4653%
P/E Ratio21.74N/A-
Revenue2.57B242M1,061%
Total Cash940M395M238%
Total Debt1.65B516M321%
FUNDAMENTALS RATINGS
NVST vs TMDX: Fundamental Ratings
NVST
TMDX
OUTLOOK RATING
1..100
7951
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
10050
SMR RATING
1..100
9641
PRICE GROWTH RATING
1..100
4645
P/E GROWTH RATING
1..100
86100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (63) in the null industry is in the same range as TMDX (81) in the Medical Specialties industry. This means that NVST’s stock grew similarly to TMDX’s over the last 12 months.

TMDX's Profit vs Risk Rating (50) in the Medical Specialties industry is somewhat better than the same rating for NVST (100) in the null industry. This means that TMDX’s stock grew somewhat faster than NVST’s over the last 12 months.

TMDX's SMR Rating (41) in the Medical Specialties industry is somewhat better than the same rating for NVST (96) in the null industry. This means that TMDX’s stock grew somewhat faster than NVST’s over the last 12 months.

TMDX's Price Growth Rating (45) in the Medical Specialties industry is in the same range as NVST (46) in the null industry. This means that TMDX’s stock grew similarly to NVST’s over the last 12 months.

NVST's P/E Growth Rating (86) in the null industry is in the same range as TMDX (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to TMDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTTMDX
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
67%
Bullish Trend 19 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 1 day ago
80%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TMDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJSTX13.550.18
+1.35%
VY® JPMorgan Small Cap Core Equity S2
SUFCX38.840.46
+1.20%
NAA Mid Growth C
VWNDX21.600.13
+0.61%
Vanguard Windsor Investor Shares
FANAX44.930.20
+0.45%
Fidelity Advisor Energy A
MKDCX26.31-0.01
-0.05%
BlackRock Emerging Mkts K

TMDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with RDNT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then RDNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMDX
1D Price
Change %
TMDX100%
-0.71%
RDNT - TMDX
37%
Loosely correlated
+2.76%
NVST - TMDX
34%
Loosely correlated
+0.15%
SMTI - TMDX
33%
Loosely correlated
+0.84%
ALGN - TMDX
33%
Loosely correlated
+1.07%
GKOS - TMDX
32%
Poorly correlated
+0.51%
More